Finally, we investigated the cell-type specificity of the response to deletion of the regions encompassing the PCa risk-associated CTCF sites by also deleting these regions in HEK293T kidney cells and HAP1 chronic myelogenous leukemia cells. Here, CTCF is linked to chronic myelogenous leukemia, BCR-ABL1 positive.